MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager

MoonLake Immunotherapeutics

NASDAQ:MLTX

Watchlist

Dividends

Discount Rate

Price: 51.89 USD -1.35% Market Closed

Market Cap: 3.3B USD

Have any thoughts about
MoonLake Immunotherapeutics?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 51.89 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MLTX Alert

MoonLake Immunotherapeutics

51.89

-0.71 (-1.35%)

52 Week Range	36.67 63.86
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

MoonLake Immunotherapeutics

What unique competitive advantages
does MoonLake Immunotherapeutics hold over its rivals?

What risks and challenges
does MoonLake Immunotherapeutics face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of MoonLake Immunotherapeutics.

What unique competitive advantages
does MoonLake Immunotherapeutics hold over its rivals?

What risks and challenges
does MoonLake Immunotherapeutics face in the near future?

Has there been any significant insider trading activity
in MoonLake Immunotherapeutics recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MoonLake Immunotherapeutics.

Provide P/S
for MoonLake Immunotherapeutics.

Provide P/E
for MoonLake Immunotherapeutics.

Provide P/OCF
for MoonLake Immunotherapeutics.

Provide P/FCFE
for MoonLake Immunotherapeutics.

Provide P/B
for MoonLake Immunotherapeutics.

Provide EV/S
for MoonLake Immunotherapeutics.

Provide EV/GP
for MoonLake Immunotherapeutics.

Provide EV/EBITDA
for MoonLake Immunotherapeutics.

Provide EV/EBIT
for MoonLake Immunotherapeutics.

Provide EV/OCF
for MoonLake Immunotherapeutics.

Provide EV/FCFF
for MoonLake Immunotherapeutics.

Provide EV/IC
for MoonLake Immunotherapeutics.

Show me price targets
for MoonLake Immunotherapeutics made by professional analysts.

What are the Revenue projections
for MoonLake Immunotherapeutics?

How accurate were the past Revenue estimates
for MoonLake Immunotherapeutics?

What are the Net Income projections
for MoonLake Immunotherapeutics?

How accurate were the past Net Income estimates
for MoonLake Immunotherapeutics?

What are the EPS projections
for MoonLake Immunotherapeutics?

How accurate were the past EPS estimates
for MoonLake Immunotherapeutics?

What are the EBIT projections
for MoonLake Immunotherapeutics?

How accurate were the past EBIT estimates
for MoonLake Immunotherapeutics?

Compare the revenue forecasts
for MoonLake Immunotherapeutics with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MoonLake Immunotherapeutics and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MoonLake Immunotherapeutics against its competitors.

Analyze the profit margins
(gross, operating, and net) of MoonLake Immunotherapeutics compared to its peers.

Compare the P/E ratios
of MoonLake Immunotherapeutics against its peers.

Discuss the investment returns and shareholder value creation
comparing MoonLake Immunotherapeutics with its peers.

Analyze the financial leverage
of MoonLake Immunotherapeutics compared to its main competitors.

Show all profitability ratios
for MoonLake Immunotherapeutics.

Provide ROE
for MoonLake Immunotherapeutics.

Provide ROA
for MoonLake Immunotherapeutics.

Provide ROIC
for MoonLake Immunotherapeutics.

Provide ROCE
for MoonLake Immunotherapeutics.

Provide Gross Margin
for MoonLake Immunotherapeutics.

Provide Operating Margin
for MoonLake Immunotherapeutics.

Provide Net Margin
for MoonLake Immunotherapeutics.

Provide FCF Margin
for MoonLake Immunotherapeutics.

Show all solvency ratios
for MoonLake Immunotherapeutics.

Provide D/E Ratio
for MoonLake Immunotherapeutics.

Provide D/A Ratio
for MoonLake Immunotherapeutics.

Provide Interest Coverage Ratio
for MoonLake Immunotherapeutics.

Provide Altman Z-Score Ratio
for MoonLake Immunotherapeutics.

Provide Quick Ratio
for MoonLake Immunotherapeutics.

Provide Current Ratio
for MoonLake Immunotherapeutics.

Provide Cash Ratio
for MoonLake Immunotherapeutics.

What is the historical Revenue growth
over the last 5 years for MoonLake Immunotherapeutics?

What is the historical Net Income growth
over the last 5 years for MoonLake Immunotherapeutics?

What is the current Free Cash Flow
of MoonLake Immunotherapeutics?

Discuss the annual earnings per share (EPS)
trend over the past five years for MoonLake Immunotherapeutics.

MLTX

Cash Flow Statement

Cash from Financing Activities

MoonLake Immunotherapeutics
Cash from Financing Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

MoonLake Immunotherapeutics
Cash from Financing Activities Peer Comparison

Comparables:

ADCT

ACIU

CRSP

MOLN

XLS

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company		Cash from Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
M	MoonLake Immunotherapeutics NASDAQ:MLTX	Cash from Financing Activities $479.7m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	ADC Therapeutics SA NYSE:ADCT	Cash from Financing Activities $73.9m	CAGR 3-Years -47%	CAGR 5-Years N/A	CAGR 10-Years N/A
	AC Immune SA NASDAQ:ACIU	Cash from Financing Activities CHf40.7m	CAGR 3-Years 77%	CAGR 5-Years -24%	CAGR 10-Years N/A
	CRISPR Therapeutics AG NASDAQ:CRSP	Cash from Financing Activities $354.1m	CAGR 3-Years -19%	CAGR 5-Years 23%	CAGR 10-Years N/A
	Molecular Partners AG SIX:MOLN	Cash from Financing Activities -CHf1.2m	CAGR 3-Years N/A	CAGR 5-Years -52%	CAGR 10-Years N/A
	Xlife Sciences AG SIX:XLS	Cash from Financing Activities CHf828.6k	CAGR 3-Years -49%	CAGR 5-Years N/A	CAGR 10-Years N/A

What is MoonLake Immunotherapeutics's Cash from Financing Activities?

Cash from Financing Activities
479.7m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Cash from Financing Activities amounts to 479.7m USD.

What is MoonLake Immunotherapeutics's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 1Y
301%

Over the last year, the Cash from Financing Activities growth was 301%.

MoonLake Immunotherapeutics
NASDAQ:MLTX

MoonLake Immunotherapeutics
Cash from Financing Activities

MoonLake Immunotherapeutics
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

See Also

What is MoonLake Immunotherapeutics's Cash from Financing Activities?

Cash from Financing Activities
479.7m USD

What is MoonLake Immunotherapeutics's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 1Y
301%

Company

Help

Tools

Stocks

MoonLake Immunotherapeutics NASDAQ:MLTX

MoonLake Immunotherapeutics Cash from Financing Activities

MoonLake Immunotherapeutics Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis Latest Figures & CAGR of Competitors

See Also

What is MoonLake Immunotherapeutics's Cash from Financing Activities? Cash from Financing Activities 479.7m USD

What is MoonLake Immunotherapeutics's Cash from Financing Activities growth rate? Cash from Financing Activities CAGR 1Y 301%

Company

Help

Tools

Stocks

MoonLake Immunotherapeutics
NASDAQ:MLTX

MoonLake Immunotherapeutics
Cash from Financing Activities

MoonLake Immunotherapeutics
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

What is MoonLake Immunotherapeutics's Cash from Financing Activities?

Cash from Financing Activities
479.7m USD

What is MoonLake Immunotherapeutics's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 1Y
301%